- US12178842utility2024PCSK9 Antagonist Compounds0 cites
- US12180219utility2024Process for Preparing Beta 3 Agonists and Intermediates0 cites
- US12180226utility2024Spirotricycle RIPK1 Inhibitors and Methods of Uses Thereof0 cites
- US12171776utility2024Methods for Treatment and Prophylaxis of HIV and AIDS0 cites
- US12175679utility20243D Segmentation of Lesions in CT Images Using Self-supervised Pretraining with Augmentation0 cites
- US12168004utility2024Treatment of Migraine0 cites
- US12161721utility2024Processes for the Formulation of Pneumococcal Polysaccharides for Conjugation to a Carrier Protein0 cites
- US12162938utility2024Purification Process for Removal of Tyrosine Sulfation Antibody Variants; Purified Compositions0 cites
- US12157727utility2024Substituted Tetrahydroquinolin Compounds as Indoleamine 2,3-dioxygenase (IDO) Inhibitors0 cites
- US12152019utility2024Arylalkyl Pyrazole Compounds as Indoleamine 2,3-dioxygenase Inhibitors0 cites
- US12122834utility2024Anti-pd-1 Antibodies0 cites
- US12110330utility2024Compositions of Programmed Death Receptor 1 (PD-1) Antibodies and Methods of Obtaining the Compositions Thereof0 cites
- US12102680utility2024Anti-tigit Antibodies0 cites
- US12102681utility2024Anti-lag3 Antibodies and Antigen-binding Fragments0 cites
- US12097250utility2024Compositions Comprising Streptococcus Pneumoniae Polysaccharide-protein Conjugates and Methods of Use Thereof0 cites
- US12091405utility2024Substituted Pyrazole Compounds as Indoleamine 2,3-dioxygenase Inhibitors0 cites
- US12083112utility2024Combination of a PD-1 Antagonist and a VEGFR/FGFR/RET Tyrosine Kinase Inhibitor for Treating Cancer0 cites
- US12084651utility2024Surface Display of Whole Antibodies in Eukaryotes0 cites
- US12065438utility2024Substituted Tricyclic Compounds as Indoleamine 2,3-dioxygenase Inhibitors0 cites